Formulation Development

03rd July 2024

Mastering the art of formulation development requires specialized expertise, technologies, and facilities to ensure a formulation is both safe and stable, and that it can achieve its target product profile (TPP).

At Abzena, our experienced formulation scientists specialize in developing complex biological compounds. We leverage our comprehensive knowledge from having delivered over 1400+ programs and the latest technologies to assist in optimizing each formulation for solubility, delivery, safety, and sustained stability.

Our customer-centric approach across a broad range of formulation services enables us to support a biopharmaceutical product throughout its entire lifecycle —from initial pre-formulation studies and generation of a formulation to support toxicology and first-in-human (FIH) clinical trials through to clinical in-use studies, formulation optimization, robustness, and device interaction studies.

Our capabilities include:

  • Mass spectrometry instruments (TOF MS, QTOF MS)
  • Particle size assessment platforms
  • Biophysical stability assessment platforms
  • UPLC/HPLC systems

Click here to access our formulation development info sheet to discover how our expert team, technologies, and capabilities can accelerate your biologic or bioconjugate towards the clinic today.